...
首页> 外文期刊>Journal of vascular surgery >Family history of aortic disease predicts disease patterns and progression and is a significant influence on management strategies for patients and their relatives
【24h】

Family history of aortic disease predicts disease patterns and progression and is a significant influence on management strategies for patients and their relatives

机译:主动脉疾病的家族史可预测疾病的类型和进展,并且对患者及其亲属的治疗策略具有重大影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: While a positive family history (FH) is a known risk factor for developing an aneurysm, its association with the extent of disease has not been established. We evaluated the influence of a FH of aortic disease with respect to the pattern and distribution of aortic aneurysms in a given patient. Methods and Results: From November 1999 to November 2011, 1263 patients were enrolled in physician-sponsored endovascular device trials to treat aortic aneurysms. Of the 555 patients who were alive and returning for follow-up, we obtained 426 (77%) family histories. Three-dimensional imaging studies were used to identify the presence of aneurysms; 36% (155/426) of patients had a FH of aortic aneurysms and 5% (21/155) had isolated intracranial aneurysms. A logistic regression model was used to compare aortic morphology between patients with a positive or negative FH for aneurysms. Patients with a positive FH of aortic aneurysms were younger at their initial aneurysm (63 vs 70 years; P <.0001), more frequently had proximal aortic involvement (root: odds ratio [OR], 5.4; P <.0001; ascending: OR, 2.9; P <.001; thoracic: OR, 2.2; P =.01) with over 50% of FH patients ultimately developing suprarenal aortic involvement (P =.0001) and had a greater incidence of bilateral iliac artery aneurysm (OR, 1.8; P =.03). Conclusions: FH is an important tool that provides insight into the expected behavior of the untreated aorta and has significant implications for the development of treatment strategies. These findings should be used to guide patient's management with regard to treatment, follow-up paradigms, genetic testing, and screening of other family members.
机译:背景:虽然家族史(FH)阳性是发展为动脉瘤的已知危险因素,但尚未确定其与疾病范围的相关性。我们评估了特定患者中主动脉疾病FH对主动脉瘤的类型和分布的影响。方法和结果:从1999年11月至2011年11月,有1263例患者参加了由医生赞助的血管内装置治疗主动脉瘤的治疗。在555名还活着并返回随访的患者中,我们获得了426例(77%)家族病史。三维成像研究被用来识别动脉瘤的存在。 36%(155/426)的患者患有FH主动脉瘤,而5%(21/155)的患者患有颅内动脉瘤。使用Logistic回归模型比较FH阳性或阴性的动脉瘤患者之间的主动脉形态。主动脉瘤FH阳性的患者在其初次动脉瘤中较年轻(63岁对70岁; P <.0001),主动脉近端受累的频率更高(根:比值比[OR],5.4; P <.0001;上升: OR,2.9; P <.001;胸部:OR,2.2; P = .01),超过50%的FH患者最终发展为肾上主动脉受累(P = .0001),双侧动脉瘤的发生率更高(OR ,1.8; P = .03)。结论:FH是一种重要工具,可深入了解未治疗主动脉的预期行为,并对治疗策略的发展具有重要意义。这些发现应被用于指导患者在治疗,随访范例,基因检测和其他家庭成员筛查方面的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号